[email protected]
CDI - Contrive Datum Insights
Healthcare Services

Genomics Services MarketSize, Share & Industry Analysis, 2026-2034By Service TypeBy Sequencing TechnologyBy ApplicationBy Workflow StageBy End UserBy Sample TypeBy Disease AreaBy Service Provider ModelBy Project ScaleBy Delivery ModelBy Regulatory and Accreditation Status

Full title & scope — all 11 axes with their segments

Genomics Services Market Size, Share & Industry Analysis, By Service Type (Next-Generation Sequencing Services, Sanger Sequencing Services, Microarray Services, Genotyping Services, Epigenomics Services, Bioinformatics and Data Analysis Services, Other Genomics Services), By Sequencing Technology (Short-Read Sequencing, Long-Read Sequencing, Sanger Sequencing, Microarray-Based Platforms, Real-Time PCR and Digital PCR), By Application (Research, Clinical Diagnostics, Drug Discovery and Development, Precision and Personalized Medicine, Agriculture and Animal Genomics, Consumer Genomics), By Workflow Stage (Sample Preparation and Library Construction, Sequencing / Data Generation, Primary and Secondary Analysis, Tertiary Analysis and Interpretation, Reporting and Data Management), By End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Hospitals and Diagnostic Laboratories, Government and Public Health Agencies, Agricultural and Food Companies, Direct-to-Consumer), By Sample Type (Blood, Tissue, Saliva and Buccal Swab, Microbial and Environmental Samples, Plant and Animal Samples, Other Sample Types), By Disease Area (Oncology, Rare and Genetic Disorders, Infectious Diseases, Cardiovascular Diseases, Neurological Disorders, Reproductive Health, Other Disease Areas), By Service Provider Model (Core Facility and Academic Service Labs, Commercial Genomics Service Providers, Instrument Vendor Service Divisions, Clinical Reference Laboratories, Contract Research Organization Genomics Units), By Project Scale (Single-Sample and Small-Batch Projects, Mid-Scale Cohort Studies, Population-Scale and Biobank Programs, Ongoing Routine Testing Volumes), By Delivery Model (Outsourced Service Contracts, Fee-for-Service Per Sample, Subscription and Bundled Analysis Plans, Partnership and Collaborative Programs), By Regulatory and Accreditation Status (Research Use Only, CLIA / CAP Certified Clinical, ISO 15189 Accredited, CE-IVD / FDA-Cleared or Approved Assays), and Regional Forecast, 2026-2034

Last Updated: Nov 18, 2026Format: PDFReport ID: CDI-248907
TOC

Full table of contents for the published report, chapter by chapter.

Full chapter-and-section structure of the report. Segment, region, and company breakdowns are listed as scope. The underlying figures are in the sample and full report.

Table of Contents+
Chapter 1.Executive Summary
1.1Strategic Imperatives
1.2Definition
1.3Genomics Services Comparison By Segments
Chapter 2.Premium Insights
2.1Top 3 Trends to Watch
2.2Top 3 Strategies Followed by Major Players
2.3Top 3 Predictions by Contrive Datum Insights
2.4Top Investment Pockets
2.4.1Market Attractiveness Analysis, By Service Type
2.4.2Market Attractiveness Analysis, By Sequencing Technology
2.4.3Market Attractiveness Analysis, By Application
2.4.4Market Attractiveness Analysis, By Workflow Stage
2.4.5Market Attractiveness Analysis, By End User
2.4.6Market Attractiveness Analysis, By Sample Type
2.4.7Market Attractiveness Analysis, By Disease Area
2.4.8Market Attractiveness Analysis, By Service Provider Model
2.4.9Market Attractiveness Analysis, By Project Scale
2.4.10Market Attractiveness Analysis, By Delivery Model
2.4.11Market Attractiveness Analysis, By Regulatory and Accreditation Status
2.5Key Market Participants — Intensity Mapping
2.6Insights From Primary Respondents
Chapter 3.Market Definition
Chapter 4.Research Methodology
4.1Research Approach
4.1.1Research Programs / Design
4.1.2Market Size Estimation
4.2Data Sources
4.2.1Secondary Sources
4.2.1.1Preliminary Data Mining
4.2.2Primary Sources
4.2.2.1Statistical Model
4.2.2.2Data Triangulation
4.2.2.3Research Objective
4.3Flow Of Methodology
4.4Top-Down / Bottom-Up Approach
Chapter 5.Strategic Imperatives & Market Outlook
Chapter 6.Go-to-Market (GTM) Strategies
6.1Market Focus & Value Proposition
6.1.1Target Customers, Priority Markets, and Core Value Proposition
6.1.2Product Differentiation and Positioning Logic
6.2Commercial Model & Pricing Strategy
6.2.1Pricing Approach and Value Capture
6.2.2Contracting, Bundling, and Monetization Framework
6.3Channels, Sales & Partnerships
6.3.1Direct and Indirect Channel Strategy
6.3.2Sales Execution Model and Strategic Partnerships
6.4Marketing, Launch & Execution Roadmap
6.4.1Marketing and Demand Generation Approach
6.4.2Launch Sequencing and Rollout Plan
6.5Operational Readiness & Governance KPIs
6.5.1Supply Chain and Operational Preparedness
6.5.2Regulatory Considerations, Risks, and Performance Tracking
Chapter 7.Market Trends, Strategy & Dynamics
7.1Trends Overview
7.2Strategic Overview
7.3Market Drivers
7.4Market Restraints
7.5Market Opportunities
7.6Market Challenges
7.7Impact Analysis of Market Dynamics
Chapter 8.Porter's Five Forces
8.1Bargaining Power of Suppliers
8.2Bargaining Power of Buyers
8.3Threat of New Entrants
8.4Threat of Substitutes
8.5Competitive Rivalry
Chapter 9.PESTEL Analysis
9.1Political
9.2Economic
9.3Social
9.4Technological
9.5Environmental
9.6Legal
Chapter 10.Value Chain Analysis
Chapter 11.Supply Chain Analysis
Chapter 12.Macro-Economic Factors
12.1Macro-Economic Factors Overview
12.2Forecast Factors — Relevance and Impact
Chapter 13.Market Cost Analysis
13.1Key Raw Materials Analysis
13.1.1Key Raw Materials
13.1.2Price Trend of Key Raw Materials
13.1.3Key Suppliers of Raw Materials
13.1.4Market Concentration Rate of Raw Materials
13.1.5Raw Materials
13.1.6Labor Cost
Chapter 14.Market Supply-Side Analysis
14.1Raw Materials
14.2Price Trends
14.3Industry Chain
14.4Raw Materials Sourcing
14.5Raw Materials Sources of Major Manufacturers
14.6Downstream Buyers
Chapter 15.Global Genomics Services Market Size & Projections, 2020–2034, Revenue (USD Billion)
15.1Global Genomics Services Market Size — Total
15.2Market Size, by Segment (By Service Type, By Sequencing Technology, By Application, By Workflow Stage, By End User, By Sample Type, By Disease Area, By Service Provider Model, By Project Scale, By Delivery Model, By Regulatory and Accreditation Status)
Chapter 16.Global Genomics Services Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
16.1Introduction
16.2Global Genomics Services Market Size, By Service Type, 2020–2034, Revenue (USD Billion)
16.3Global Genomics Services Market Share, By Service Type (%)
16.3.1Next-Generation Sequencing Services
16.3.1.1Market Size, By Next-Generation Sequencing Services, 2020–2034, Revenue (USD Billion)
16.3.1.2Next-Generation Sequencing Services Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
16.3.1.3Next-Generation Sequencing Services Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
16.3.1.4Next-Generation Sequencing Services Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
16.3.1.5Next-Generation Sequencing Services Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
16.3.1.6Next-Generation Sequencing Services Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
16.3.1.7Next-Generation Sequencing Services Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
16.3.1.8Next-Generation Sequencing Services Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
16.3.1.9Next-Generation Sequencing Services Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
16.3.1.10Next-Generation Sequencing Services Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
16.3.1.11Next-Generation Sequencing Services Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
16.3.2Sanger Sequencing Services
16.3.3Microarray Services
16.3.4Genotyping Services
16.3.5Epigenomics Services
16.3.6Bioinformatics and Data Analysis Services
16.3.7Other Genomics Services
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 16.3.1 (Next-Generation Sequencing Services).
Chapter 17.Global Genomics Services Market Overview, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
17.1Introduction
17.2Global Genomics Services Market Size, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
17.3Global Genomics Services Market Share, By Sequencing Technology (%)
17.3.1Short-Read Sequencing
17.3.1.1Market Size, By Short-Read Sequencing, 2020–2034, Revenue (USD Billion)
17.3.1.2Short-Read Sequencing Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
17.3.1.3Short-Read Sequencing Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
17.3.1.4Short-Read Sequencing Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
17.3.1.5Short-Read Sequencing Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
17.3.1.6Short-Read Sequencing Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
17.3.1.7Short-Read Sequencing Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
17.3.1.8Short-Read Sequencing Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
17.3.1.9Short-Read Sequencing Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
17.3.1.10Short-Read Sequencing Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
17.3.1.11Short-Read Sequencing Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
17.3.2Long-Read Sequencing
17.3.3Sanger Sequencing
17.3.4Microarray-Based Platforms
17.3.5Real-Time PCR and Digital PCR
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 17.3.1 (Short-Read Sequencing).
Chapter 18.Global Genomics Services Market Overview, By Application, 2020–2034, Revenue (USD Billion)
18.1Introduction
18.2Global Genomics Services Market Size, By Application, 2020–2034, Revenue (USD Billion)
18.3Global Genomics Services Market Share, By Application (%)
18.3.1Research
18.3.1.1Market Size, By Research, 2020–2034, Revenue (USD Billion)
18.3.1.2Research Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
18.3.1.3Research Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
18.3.1.4Research Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
18.3.1.5Research Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
18.3.1.6Research Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
18.3.1.7Research Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
18.3.1.8Research Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
18.3.1.9Research Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
18.3.1.10Research Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
18.3.1.11Research Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
18.3.2Clinical Diagnostics
18.3.3Drug Discovery and Development
18.3.4Precision and Personalized Medicine
18.3.5Agriculture and Animal Genomics
18.3.6Consumer Genomics
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 18.3.1 (Research).
Chapter 19.Global Genomics Services Market Overview, By Workflow Stage, 2020–2034, Revenue (USD Billion)
19.1Introduction
19.2Global Genomics Services Market Size, By Workflow Stage, 2020–2034, Revenue (USD Billion)
19.3Global Genomics Services Market Share, By Workflow Stage (%)
19.3.1Sample Preparation and Library Construction
19.3.1.1Market Size, By Sample Preparation and Library Construction, 2020–2034, Revenue (USD Billion)
19.3.1.2Sample Preparation and Library Construction Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
19.3.1.3Sample Preparation and Library Construction Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
19.3.1.4Sample Preparation and Library Construction Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
19.3.1.5Sample Preparation and Library Construction Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
19.3.1.6Sample Preparation and Library Construction Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
19.3.1.7Sample Preparation and Library Construction Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
19.3.1.8Sample Preparation and Library Construction Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
19.3.1.9Sample Preparation and Library Construction Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
19.3.1.10Sample Preparation and Library Construction Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
19.3.1.11Sample Preparation and Library Construction Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
19.3.2Sequencing / Data Generation
19.3.3Primary and Secondary Analysis
19.3.4Tertiary Analysis and Interpretation
19.3.5Reporting and Data Management
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 19.3.1 (Sample Preparation and Library Construction).
Chapter 20.Global Genomics Services Market Overview, By End User, 2020–2034, Revenue (USD Billion)
20.1Introduction
20.2Global Genomics Services Market Size, By End User, 2020–2034, Revenue (USD Billion)
20.3Global Genomics Services Market Share, By End User (%)
20.3.1Academic and Research Institutes
20.3.1.1Market Size, By Academic and Research Institutes, 2020–2034, Revenue (USD Billion)
20.3.1.2Academic and Research Institutes Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
20.3.1.3Academic and Research Institutes Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
20.3.1.4Academic and Research Institutes Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
20.3.1.5Academic and Research Institutes Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
20.3.1.6Academic and Research Institutes Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
20.3.1.7Academic and Research Institutes Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
20.3.1.8Academic and Research Institutes Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
20.3.1.9Academic and Research Institutes Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
20.3.1.10Academic and Research Institutes Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
20.3.1.11Academic and Research Institutes Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
20.3.2Pharmaceutical and Biotechnology Companies
20.3.3Contract Research Organizations
20.3.4Hospitals and Diagnostic Laboratories
20.3.5Government and Public Health Agencies
20.3.6Agricultural and Food Companies
20.3.7Direct-to-Consumer
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 20.3.1 (Academic and Research Institutes).
Chapter 21.Global Genomics Services Market Overview, By Sample Type, 2020–2034, Revenue (USD Billion)
21.1Introduction
21.2Global Genomics Services Market Size, By Sample Type, 2020–2034, Revenue (USD Billion)
21.3Global Genomics Services Market Share, By Sample Type (%)
21.3.1Blood
21.3.1.1Market Size, By Blood, 2020–2034, Revenue (USD Billion)
21.3.1.2Blood Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
21.3.1.3Blood Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
21.3.1.4Blood Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
21.3.1.5Blood Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
21.3.1.6Blood Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
21.3.1.7Blood Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
21.3.1.8Blood Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
21.3.1.9Blood Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
21.3.1.10Blood Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
21.3.1.11Blood Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
21.3.2Tissue
21.3.3Saliva and Buccal Swab
21.3.4Microbial and Environmental Samples
21.3.5Plant and Animal Samples
21.3.6Other Sample Types
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 21.3.1 (Blood).
Chapter 22.Global Genomics Services Market Overview, By Disease Area, 2020–2034, Revenue (USD Billion)
22.1Introduction
22.2Global Genomics Services Market Size, By Disease Area, 2020–2034, Revenue (USD Billion)
22.3Global Genomics Services Market Share, By Disease Area (%)
22.3.1Oncology
22.3.1.1Market Size, By Oncology, 2020–2034, Revenue (USD Billion)
22.3.1.2Oncology Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
22.3.1.3Oncology Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
22.3.1.4Oncology Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
22.3.1.5Oncology Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
22.3.1.6Oncology Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
22.3.1.7Oncology Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
22.3.1.8Oncology Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
22.3.1.9Oncology Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
22.3.1.10Oncology Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
22.3.1.11Oncology Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
22.3.2Rare and Genetic Disorders
22.3.3Infectious Diseases
22.3.4Cardiovascular Diseases
22.3.5Neurological Disorders
22.3.6Reproductive Health
22.3.7Other Disease Areas
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 22.3.1 (Oncology).
Chapter 23.Global Genomics Services Market Overview, By Service Provider Model, 2020–2034, Revenue (USD Billion)
23.1Introduction
23.2Global Genomics Services Market Size, By Service Provider Model, 2020–2034, Revenue (USD Billion)
23.3Global Genomics Services Market Share, By Service Provider Model (%)
23.3.1Core Facility and Academic Service Labs
23.3.1.1Market Size, By Core Facility and Academic Service Labs, 2020–2034, Revenue (USD Billion)
23.3.1.2Core Facility and Academic Service Labs Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
23.3.1.3Core Facility and Academic Service Labs Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
23.3.1.4Core Facility and Academic Service Labs Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
23.3.1.5Core Facility and Academic Service Labs Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
23.3.1.6Core Facility and Academic Service Labs Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
23.3.1.7Core Facility and Academic Service Labs Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
23.3.1.8Core Facility and Academic Service Labs Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
23.3.1.9Core Facility and Academic Service Labs Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
23.3.1.10Core Facility and Academic Service Labs Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
23.3.1.11Core Facility and Academic Service Labs Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
23.3.2Commercial Genomics Service Providers
23.3.3Instrument Vendor Service Divisions
23.3.4Clinical Reference Laboratories
23.3.5Contract Research Organization Genomics Units
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 23.3.1 (Core Facility and Academic Service Labs).
Chapter 24.Global Genomics Services Market Overview, By Project Scale, 2020–2034, Revenue (USD Billion)
24.1Introduction
24.2Global Genomics Services Market Size, By Project Scale, 2020–2034, Revenue (USD Billion)
24.3Global Genomics Services Market Share, By Project Scale (%)
24.3.1Single-Sample and Small-Batch Projects
24.3.1.1Market Size, By Single-Sample and Small-Batch Projects, 2020–2034, Revenue (USD Billion)
24.3.1.2Single-Sample and Small-Batch Projects Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
24.3.1.3Single-Sample and Small-Batch Projects Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
24.3.1.4Single-Sample and Small-Batch Projects Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
24.3.1.5Single-Sample and Small-Batch Projects Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
24.3.1.6Single-Sample and Small-Batch Projects Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
24.3.1.7Single-Sample and Small-Batch Projects Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
24.3.1.8Single-Sample and Small-Batch Projects Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
24.3.1.9Single-Sample and Small-Batch Projects Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
24.3.1.10Single-Sample and Small-Batch Projects Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
24.3.1.11Single-Sample and Small-Batch Projects Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
24.3.2Mid-Scale Cohort Studies
24.3.3Population-Scale and Biobank Programs
24.3.4Ongoing Routine Testing Volumes
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 24.3.1 (Single-Sample and Small-Batch Projects).
Chapter 25.Global Genomics Services Market Overview, By Delivery Model, 2020–2034, Revenue (USD Billion)
25.1Introduction
25.2Global Genomics Services Market Size, By Delivery Model, 2020–2034, Revenue (USD Billion)
25.3Global Genomics Services Market Share, By Delivery Model (%)
25.3.1Outsourced Service Contracts
25.3.1.1Market Size, By Outsourced Service Contracts, 2020–2034, Revenue (USD Billion)
25.3.1.2Outsourced Service Contracts Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
25.3.1.3Outsourced Service Contracts Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
25.3.1.4Outsourced Service Contracts Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
25.3.1.5Outsourced Service Contracts Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
25.3.1.6Outsourced Service Contracts Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
25.3.1.7Outsourced Service Contracts Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
25.3.1.8Outsourced Service Contracts Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
25.3.1.9Outsourced Service Contracts Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
25.3.1.10Outsourced Service Contracts Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
25.3.1.11Outsourced Service Contracts Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
25.3.2Fee-for-Service Per Sample
25.3.3Subscription and Bundled Analysis Plans
25.3.4Partnership and Collaborative Programs
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 25.3.1 (Outsourced Service Contracts).
Chapter 26.Global Genomics Services Market Overview, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
26.1Introduction
26.2Global Genomics Services Market Size, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
26.3Global Genomics Services Market Share, By Regulatory and Accreditation Status (%)
26.3.1Research Use Only
26.3.1.1Market Size, By Research Use Only, 2020–2034, Revenue (USD Billion)
26.3.1.2Research Use Only Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
26.3.1.3Research Use Only Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
26.3.1.4Research Use Only Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
26.3.1.5Research Use Only Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
26.3.1.6Research Use Only Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
26.3.1.7Research Use Only Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
26.3.1.8Research Use Only Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
26.3.1.9Research Use Only Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
26.3.1.10Research Use Only Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
26.3.1.11Research Use Only Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
26.3.2CLIA / CAP Certified Clinical
26.3.3ISO 15189 Accredited
26.3.4CE-IVD / FDA-Cleared or Approved Assays
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 26.3.1 (Research Use Only).
Chapter 27.Global Genomics Services Market Size — Segment Comparison
Chapter 28.Global Genomics Services Geography Overview, 2020–2034, Revenue (USD Billion)
28.1Revenue, By Geography, 2020–2034, Revenue (USD Billion)
28.2Share, By Geography, 2020–2034 (%)
28.3Share, By Geography Analysis, 2025, Market Share and CAGR
28.4Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Chapter 29.North America Genomics Services Market Deep-Dive, 2020–2034, Revenue (USD Billion)
29.1Overview, 2020–2034
29.2Size and Projections, 2020–2034, Revenue (USD Billion)
29.2.1By Service Type, 2020–2034
29.2.2By Sequencing Technology, 2020–2034
29.2.3By Application, 2020–2034
29.2.4By Workflow Stage, 2020–2034
29.2.5By End User, 2020–2034
29.2.6By Sample Type, 2020–2034
29.2.7By Disease Area, 2020–2034
29.2.8By Service Provider Model, 2020–2034
29.2.9By Project Scale, 2020–2034
29.2.10By Delivery Model, 2020–2034
29.2.11By Regulatory and Accreditation Status, 2020–2034
29.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
29.3.1US
29.3.1.1US — Key Country Dynamics
29.3.1.2US — Regulatory Framework
29.3.1.3US — Competitive Scenario
29.3.1.4US — Market Overview, 2020–2034, Revenue (USD Billion)
29.3.1.5US — Market Size and Projections, 2020–2034, Revenue (USD Billion)
29.3.1.6US Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
29.3.1.7US Market Overview, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
29.3.1.8US Market Overview, By Application, 2020–2034, Revenue (USD Billion)
29.3.1.9US Market Overview, By Workflow Stage, 2020–2034, Revenue (USD Billion)
29.3.1.10US Market Overview, By End User, 2020–2034, Revenue (USD Billion)
29.3.1.11US Market Overview, By Sample Type, 2020–2034, Revenue (USD Billion)
29.3.1.12US Market Overview, By Disease Area, 2020–2034, Revenue (USD Billion)
29.3.1.13US Market Overview, By Service Provider Model, 2020–2034, Revenue (USD Billion)
29.3.1.14US Market Overview, By Project Scale, 2020–2034, Revenue (USD Billion)
29.3.1.15US Market Overview, By Delivery Model, 2020–2034, Revenue (USD Billion)
29.3.1.16US Market Overview, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
29.3.2Canada
29.3.3Mexico
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 29.3.1 (US).
Chapter 30.Europe Genomics Services Market Deep-Dive, 2020–2034, Revenue (USD Billion)
30.1Overview, 2020–2034
30.2Size and Projections, 2020–2034, Revenue (USD Billion)
30.2.1By Service Type, 2020–2034
30.2.2By Sequencing Technology, 2020–2034
30.2.3By Application, 2020–2034
30.2.4By Workflow Stage, 2020–2034
30.2.5By End User, 2020–2034
30.2.6By Sample Type, 2020–2034
30.2.7By Disease Area, 2020–2034
30.2.8By Service Provider Model, 2020–2034
30.2.9By Project Scale, 2020–2034
30.2.10By Delivery Model, 2020–2034
30.2.11By Regulatory and Accreditation Status, 2020–2034
30.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
30.3.1Germany
30.3.1.1Germany — Key Country Dynamics
30.3.1.2Germany — Regulatory Framework
30.3.1.3Germany — Competitive Scenario
30.3.1.4Germany — Market Overview, 2020–2034, Revenue (USD Billion)
30.3.1.5Germany — Market Size and Projections, 2020–2034, Revenue (USD Billion)
30.3.1.6Germany Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
30.3.1.7Germany Market Overview, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
30.3.1.8Germany Market Overview, By Application, 2020–2034, Revenue (USD Billion)
30.3.1.9Germany Market Overview, By Workflow Stage, 2020–2034, Revenue (USD Billion)
30.3.1.10Germany Market Overview, By End User, 2020–2034, Revenue (USD Billion)
30.3.1.11Germany Market Overview, By Sample Type, 2020–2034, Revenue (USD Billion)
30.3.1.12Germany Market Overview, By Disease Area, 2020–2034, Revenue (USD Billion)
30.3.1.13Germany Market Overview, By Service Provider Model, 2020–2034, Revenue (USD Billion)
30.3.1.14Germany Market Overview, By Project Scale, 2020–2034, Revenue (USD Billion)
30.3.1.15Germany Market Overview, By Delivery Model, 2020–2034, Revenue (USD Billion)
30.3.1.16Germany Market Overview, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
30.3.2France
30.3.3Italy
30.3.4Spain
30.3.5UK
30.3.6Nordic Countries
30.3.7Benelux Union
30.3.8Rest of Europe
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 30.3.1 (Germany).
Chapter 31.Asia Pacific Genomics Services Market Deep-Dive, 2020–2034, Revenue (USD Billion)
31.1Overview, 2020–2034
31.2Size and Projections, 2020–2034, Revenue (USD Billion)
31.2.1By Service Type, 2020–2034
31.2.2By Sequencing Technology, 2020–2034
31.2.3By Application, 2020–2034
31.2.4By Workflow Stage, 2020–2034
31.2.5By End User, 2020–2034
31.2.6By Sample Type, 2020–2034
31.2.7By Disease Area, 2020–2034
31.2.8By Service Provider Model, 2020–2034
31.2.9By Project Scale, 2020–2034
31.2.10By Delivery Model, 2020–2034
31.2.11By Regulatory and Accreditation Status, 2020–2034
31.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
31.3.1India
31.3.1.1India — Key Country Dynamics
31.3.1.2India — Regulatory Framework
31.3.1.3India — Competitive Scenario
31.3.1.4India — Market Overview, 2020–2034, Revenue (USD Billion)
31.3.1.5India — Market Size and Projections, 2020–2034, Revenue (USD Billion)
31.3.1.6India Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
31.3.1.7India Market Overview, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
31.3.1.8India Market Overview, By Application, 2020–2034, Revenue (USD Billion)
31.3.1.9India Market Overview, By Workflow Stage, 2020–2034, Revenue (USD Billion)
31.3.1.10India Market Overview, By End User, 2020–2034, Revenue (USD Billion)
31.3.1.11India Market Overview, By Sample Type, 2020–2034, Revenue (USD Billion)
31.3.1.12India Market Overview, By Disease Area, 2020–2034, Revenue (USD Billion)
31.3.1.13India Market Overview, By Service Provider Model, 2020–2034, Revenue (USD Billion)
31.3.1.14India Market Overview, By Project Scale, 2020–2034, Revenue (USD Billion)
31.3.1.15India Market Overview, By Delivery Model, 2020–2034, Revenue (USD Billion)
31.3.1.16India Market Overview, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
31.3.2Australia
31.3.3China
31.3.4China (Taiwan)
31.3.5Japan
31.3.6South Korea
31.3.7Southeast Asia
31.3.8Indonesia
31.3.9Thailand
31.3.10Malaysia
31.3.11Singapore
31.3.12Rest of Asia Pacific
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 31.3.1 (India).
Chapter 32.Latin America Genomics Services Market Deep-Dive, 2020–2034, Revenue (USD Billion)
32.1Overview, 2020–2034
32.2Size and Projections, 2020–2034, Revenue (USD Billion)
32.2.1By Service Type, 2020–2034
32.2.2By Sequencing Technology, 2020–2034
32.2.3By Application, 2020–2034
32.2.4By Workflow Stage, 2020–2034
32.2.5By End User, 2020–2034
32.2.6By Sample Type, 2020–2034
32.2.7By Disease Area, 2020–2034
32.2.8By Service Provider Model, 2020–2034
32.2.9By Project Scale, 2020–2034
32.2.10By Delivery Model, 2020–2034
32.2.11By Regulatory and Accreditation Status, 2020–2034
32.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
32.3.1Brazil
32.3.1.1Brazil — Key Country Dynamics
32.3.1.2Brazil — Regulatory Framework
32.3.1.3Brazil — Competitive Scenario
32.3.1.4Brazil — Market Overview, 2020–2034, Revenue (USD Billion)
32.3.1.5Brazil — Market Size and Projections, 2020–2034, Revenue (USD Billion)
32.3.1.6Brazil Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
32.3.1.7Brazil Market Overview, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
32.3.1.8Brazil Market Overview, By Application, 2020–2034, Revenue (USD Billion)
32.3.1.9Brazil Market Overview, By Workflow Stage, 2020–2034, Revenue (USD Billion)
32.3.1.10Brazil Market Overview, By End User, 2020–2034, Revenue (USD Billion)
32.3.1.11Brazil Market Overview, By Sample Type, 2020–2034, Revenue (USD Billion)
32.3.1.12Brazil Market Overview, By Disease Area, 2020–2034, Revenue (USD Billion)
32.3.1.13Brazil Market Overview, By Service Provider Model, 2020–2034, Revenue (USD Billion)
32.3.1.14Brazil Market Overview, By Project Scale, 2020–2034, Revenue (USD Billion)
32.3.1.15Brazil Market Overview, By Delivery Model, 2020–2034, Revenue (USD Billion)
32.3.1.16Brazil Market Overview, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
32.3.2Argentina
32.3.3Rest of Latin America
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 32.3.1 (Brazil).
Chapter 33.Middle East and Africa Genomics Services Market Deep-Dive, 2020–2034, Revenue (USD Billion)
33.1Overview, 2020–2034
33.2Size and Projections, 2020–2034, Revenue (USD Billion)
33.2.1By Service Type, 2020–2034
33.2.2By Sequencing Technology, 2020–2034
33.2.3By Application, 2020–2034
33.2.4By Workflow Stage, 2020–2034
33.2.5By End User, 2020–2034
33.2.6By Sample Type, 2020–2034
33.2.7By Disease Area, 2020–2034
33.2.8By Service Provider Model, 2020–2034
33.2.9By Project Scale, 2020–2034
33.2.10By Delivery Model, 2020–2034
33.2.11By Regulatory and Accreditation Status, 2020–2034
33.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
33.3.1GCC
33.3.1.1GCC — Key Country Dynamics
33.3.1.2GCC — Regulatory Framework
33.3.1.3GCC — Competitive Scenario
33.3.1.4GCC — Market Overview, 2020–2034, Revenue (USD Billion)
33.3.1.5GCC — Market Size and Projections, 2020–2034, Revenue (USD Billion)
33.3.1.6GCC Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
33.3.1.7GCC Market Overview, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
33.3.1.8GCC Market Overview, By Application, 2020–2034, Revenue (USD Billion)
33.3.1.9GCC Market Overview, By Workflow Stage, 2020–2034, Revenue (USD Billion)
33.3.1.10GCC Market Overview, By End User, 2020–2034, Revenue (USD Billion)
33.3.1.11GCC Market Overview, By Sample Type, 2020–2034, Revenue (USD Billion)
33.3.1.12GCC Market Overview, By Disease Area, 2020–2034, Revenue (USD Billion)
33.3.1.13GCC Market Overview, By Service Provider Model, 2020–2034, Revenue (USD Billion)
33.3.1.14GCC Market Overview, By Project Scale, 2020–2034, Revenue (USD Billion)
33.3.1.15GCC Market Overview, By Delivery Model, 2020–2034, Revenue (USD Billion)
33.3.1.16GCC Market Overview, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
33.3.2Egypt
33.3.3South Africa
33.3.4Rest of the Middle East & Africa
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 33.3.1 (GCC).
Chapter 34.Application / Use-Case Analysis
Chapter 35.Vendor Capability Scorecard
Chapter 36.Scenario Forecasts
36.1Bull-case Trajectory
36.2Base-case Trajectory
36.3Bear-case Trajectory
Chapter 37.Top 10 Key Clients of Top 10 Players
Chapter 38.Top 10 Suppliers
Chapter 39.Competitive Landscape
39.1Illumina, Inc.
39.2Thermo Fisher Scientific Inc.
39.3BGI Genomics Co., Ltd.
39.4Eurofins Scientific SE
39.5Macrogen, Inc.
39.6Psomagen, Inc.
39.7Azenta Life Sciences (GENEWIZ)
39.8Agilent Technologies, Inc.
39.9QIAGEN N.V.
39.10Novogene Co., Ltd.
39.11Pacific Biosciences of California, Inc.
39.12Oxford Nanopore Technologies plc
39.13Element Biosciences, Inc.
39.1410x Genomics, Inc.
39.15Revvity, Inc.
39.16Charles River Laboratories International, Inc.
39.17Fulgent Genetics, Inc.
39.18GeneDx Holdings Corp.
39.19Invitae Corporation
39.20Laboratory Corporation of America Holdings (Labcorp)
39.21Quest Diagnostics Incorporated
39.22Integrated DNA Technologies, Inc.
39.23CD Genomics
39.24Genome Quebec / Genome Sciences Centre
39.25Admera Health, LLC
39.26Theragen Bio Co., Ltd.
39.27GenScript Biotech Corporation
39.28Personalis, Inc.
Chapter 40.Partnerships & M&A
Chapter 41.Key Vendor Analysis
41.1Illumina, Inc.
41.2Thermo Fisher Scientific Inc.
41.3BGI Genomics Co., Ltd.
41.4Eurofins Scientific SE
41.5Macrogen, Inc.
41.6Psomagen, Inc.
41.7Azenta Life Sciences (GENEWIZ)
41.8Agilent Technologies, Inc.
41.9QIAGEN N.V.
41.10Novogene Co., Ltd.
41.11Pacific Biosciences of California, Inc.
41.12Oxford Nanopore Technologies plc
41.13Element Biosciences, Inc.
41.1410x Genomics, Inc.
41.15Revvity, Inc.
41.16Charles River Laboratories International, Inc.
41.17Fulgent Genetics, Inc.
41.18GeneDx Holdings Corp.
41.19Invitae Corporation
41.20Laboratory Corporation of America Holdings (Labcorp)
41.21Quest Diagnostics Incorporated
41.22Integrated DNA Technologies, Inc.
41.23CD Genomics
41.24Genome Quebec / Genome Sciences Centre
41.25Admera Health, LLC
41.26Theragen Bio Co., Ltd.
41.27GenScript Biotech Corporation
41.28Personalis, Inc.
Chapter 42.Marketing Strategy Analysis, Distributors & Traders
Chapter 43.Outlook of the Market
Chapter 44.Concluding Analyst Note
List of Figures+

Structural index generated from this report's own section headings, not verified against the delivered report's actual figure numbering.

Figure 2.1Top 3 Trends to Watch
Figure 2.4Top Investment Pockets
Figure 2.4.1Market Attractiveness Analysis, By Service Type
Figure 2.4.2Market Attractiveness Analysis, By Sequencing Technology
Figure 2.4.3Market Attractiveness Analysis, By Application
Figure 2.4.4Market Attractiveness Analysis, By Workflow Stage
Figure 2.4.5Market Attractiveness Analysis, By End User
Figure 2.4.6Market Attractiveness Analysis, By Sample Type
Figure 2.4.7Market Attractiveness Analysis, By Disease Area
Figure 2.4.8Market Attractiveness Analysis, By Service Provider Model
Figure 2.4.9Market Attractiveness Analysis, By Project Scale
Figure 2.4.10Market Attractiveness Analysis, By Delivery Model
Figure 2.4.11Market Attractiveness Analysis, By Regulatory and Accreditation Status
Figure 2.5Key Market Participants — Intensity Mapping
Figure 4.2.2.2Data Triangulation
Figure 4.3Flow Of Methodology
Figure 4.4Top-Down / Bottom-Up Approach
Figure 6.1.2Product Differentiation and Positioning Logic
Figure 16.3Global Genomics Services Market Share, By Service Type (%)
Figure 17.3Global Genomics Services Market Share, By Sequencing Technology (%)
Figure 18.3Global Genomics Services Market Share, By Application (%)
Figure 19.3Global Genomics Services Market Share, By Workflow Stage (%)
Figure 20.3Global Genomics Services Market Share, By End User (%)
Figure 21.3Global Genomics Services Market Share, By Sample Type (%)
Figure 22.3Global Genomics Services Market Share, By Disease Area (%)
Figure 23.3Global Genomics Services Market Share, By Service Provider Model (%)
Figure 24.3Global Genomics Services Market Share, By Project Scale (%)
Figure 25.3Global Genomics Services Market Share, By Delivery Model (%)
Figure 26.3Global Genomics Services Market Share, By Regulatory and Accreditation Status (%)
Figure 28.2Share, By Geography, 2020–2034 (%)
Figure 28.3Share, By Geography Analysis, 2025, Market Share and CAGR
List of Tables+

Structural index generated from this report's own section headings, not verified against the delivered report's actual table numbering.

Table 1.3Genomics Services Comparison By Segments
Table 4.1.2Market Size Estimation
Table 15.1Global Genomics Services Market Size — Total
Table 15.2Market Size, by Segment (By Service Type, By Sequencing Technology, By Application, By Workflow Stage, By End User, By Sample Type, By Disease Area, By Service Provider Model, By Project Scale, By Delivery Model, By Regulatory and Accreditation Status)
Table 16.2Global Genomics Services Market Size, By Service Type, 2020–2034, Revenue (USD Billion)
Table 16.3.1.1Market Size, By Next-Generation Sequencing Services, 2020–2034, Revenue (USD Billion)
Table 16.3.1.2Next-Generation Sequencing Services Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 16.3.1.3Next-Generation Sequencing Services Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 16.3.1.4Next-Generation Sequencing Services Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 16.3.1.5Next-Generation Sequencing Services Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 16.3.1.6Next-Generation Sequencing Services Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 16.3.1.7Next-Generation Sequencing Services Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 16.3.1.8Next-Generation Sequencing Services Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 16.3.1.9Next-Generation Sequencing Services Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 16.3.1.10Next-Generation Sequencing Services Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 16.3.1.11Next-Generation Sequencing Services Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Table 17.2Global Genomics Services Market Size, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 17.3.1.1Market Size, By Short-Read Sequencing, 2020–2034, Revenue (USD Billion)
Table 17.3.1.2Short-Read Sequencing Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 17.3.1.3Short-Read Sequencing Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 17.3.1.4Short-Read Sequencing Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 17.3.1.5Short-Read Sequencing Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 17.3.1.6Short-Read Sequencing Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 17.3.1.7Short-Read Sequencing Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 17.3.1.8Short-Read Sequencing Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 17.3.1.9Short-Read Sequencing Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 17.3.1.10Short-Read Sequencing Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 17.3.1.11Short-Read Sequencing Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Table 18.2Global Genomics Services Market Size, By Application, 2020–2034, Revenue (USD Billion)
Table 18.3.1.1Market Size, By Research, 2020–2034, Revenue (USD Billion)
Table 18.3.1.2Research Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 18.3.1.3Research Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 18.3.1.4Research Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 18.3.1.5Research Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 18.3.1.6Research Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 18.3.1.7Research Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 18.3.1.8Research Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 18.3.1.9Research Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 18.3.1.10Research Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 18.3.1.11Research Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Table 19.2Global Genomics Services Market Size, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 19.3.1.1Market Size, By Sample Preparation and Library Construction, 2020–2034, Revenue (USD Billion)
Table 19.3.1.2Sample Preparation and Library Construction Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 19.3.1.3Sample Preparation and Library Construction Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 19.3.1.4Sample Preparation and Library Construction Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 19.3.1.5Sample Preparation and Library Construction Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 19.3.1.6Sample Preparation and Library Construction Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 19.3.1.7Sample Preparation and Library Construction Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 19.3.1.8Sample Preparation and Library Construction Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 19.3.1.9Sample Preparation and Library Construction Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 19.3.1.10Sample Preparation and Library Construction Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 19.3.1.11Sample Preparation and Library Construction Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Table 20.2Global Genomics Services Market Size, By End User, 2020–2034, Revenue (USD Billion)
Table 20.3.1.1Market Size, By Academic and Research Institutes, 2020–2034, Revenue (USD Billion)
Table 20.3.1.2Academic and Research Institutes Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 20.3.1.3Academic and Research Institutes Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 20.3.1.4Academic and Research Institutes Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 20.3.1.5Academic and Research Institutes Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 20.3.1.6Academic and Research Institutes Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 20.3.1.7Academic and Research Institutes Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 20.3.1.8Academic and Research Institutes Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 20.3.1.9Academic and Research Institutes Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 20.3.1.10Academic and Research Institutes Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 20.3.1.11Academic and Research Institutes Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Table 21.2Global Genomics Services Market Size, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 21.3.1.1Market Size, By Blood, 2020–2034, Revenue (USD Billion)
Table 21.3.1.2Blood Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 21.3.1.3Blood Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 21.3.1.4Blood Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 21.3.1.5Blood Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 21.3.1.6Blood Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 21.3.1.7Blood Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 21.3.1.8Blood Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 21.3.1.9Blood Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 21.3.1.10Blood Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 21.3.1.11Blood Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Table 22.2Global Genomics Services Market Size, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 22.3.1.1Market Size, By Oncology, 2020–2034, Revenue (USD Billion)
Table 22.3.1.2Oncology Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 22.3.1.3Oncology Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 22.3.1.4Oncology Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 22.3.1.5Oncology Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 22.3.1.6Oncology Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 22.3.1.7Oncology Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 22.3.1.8Oncology Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 22.3.1.9Oncology Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 22.3.1.10Oncology Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 22.3.1.11Oncology Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Table 23.2Global Genomics Services Market Size, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 23.3.1.1Market Size, By Core Facility and Academic Service Labs, 2020–2034, Revenue (USD Billion)
Table 23.3.1.2Core Facility and Academic Service Labs Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 23.3.1.3Core Facility and Academic Service Labs Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 23.3.1.4Core Facility and Academic Service Labs Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 23.3.1.5Core Facility and Academic Service Labs Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 23.3.1.6Core Facility and Academic Service Labs Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 23.3.1.7Core Facility and Academic Service Labs Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 23.3.1.8Core Facility and Academic Service Labs Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 23.3.1.9Core Facility and Academic Service Labs Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 23.3.1.10Core Facility and Academic Service Labs Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 23.3.1.11Core Facility and Academic Service Labs Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Table 24.2Global Genomics Services Market Size, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 24.3.1.1Market Size, By Single-Sample and Small-Batch Projects, 2020–2034, Revenue (USD Billion)
Table 24.3.1.2Single-Sample and Small-Batch Projects Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 24.3.1.3Single-Sample and Small-Batch Projects Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 24.3.1.4Single-Sample and Small-Batch Projects Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 24.3.1.5Single-Sample and Small-Batch Projects Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 24.3.1.6Single-Sample and Small-Batch Projects Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 24.3.1.7Single-Sample and Small-Batch Projects Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 24.3.1.8Single-Sample and Small-Batch Projects Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 24.3.1.9Single-Sample and Small-Batch Projects Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 24.3.1.10Single-Sample and Small-Batch Projects Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 24.3.1.11Single-Sample and Small-Batch Projects Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Table 25.2Global Genomics Services Market Size, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 25.3.1.1Market Size, By Outsourced Service Contracts, 2020–2034, Revenue (USD Billion)
Table 25.3.1.2Outsourced Service Contracts Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 25.3.1.3Outsourced Service Contracts Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 25.3.1.4Outsourced Service Contracts Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 25.3.1.5Outsourced Service Contracts Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 25.3.1.6Outsourced Service Contracts Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 25.3.1.7Outsourced Service Contracts Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 25.3.1.8Outsourced Service Contracts Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 25.3.1.9Outsourced Service Contracts Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 25.3.1.10Outsourced Service Contracts Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 25.3.1.11Outsourced Service Contracts Size and Projections, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Table 26.2Global Genomics Services Market Size, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Table 26.3.1.1Market Size, By Research Use Only, 2020–2034, Revenue (USD Billion)
Table 26.3.1.2Research Use Only Size and Projections, By Service Type, 2020–2034, Revenue (USD Billion)
Table 26.3.1.3Research Use Only Size and Projections, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 26.3.1.4Research Use Only Size and Projections, By Application, 2020–2034, Revenue (USD Billion)
Table 26.3.1.5Research Use Only Size and Projections, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 26.3.1.6Research Use Only Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 26.3.1.7Research Use Only Size and Projections, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 26.3.1.8Research Use Only Size and Projections, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 26.3.1.9Research Use Only Size and Projections, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 26.3.1.10Research Use Only Size and Projections, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 26.3.1.11Research Use Only Size and Projections, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 28.1Revenue, By Geography, 2020–2034, Revenue (USD Billion)
Table 28.4Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 29.1Overview, 2020–2034
Table 29.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 29.2.1By Service Type, 2020–2034
Table 29.2.2By Sequencing Technology, 2020–2034
Table 29.2.3By Application, 2020–2034
Table 29.2.4By Workflow Stage, 2020–2034
Table 29.2.5By End User, 2020–2034
Table 29.2.6By Sample Type, 2020–2034
Table 29.2.7By Disease Area, 2020–2034
Table 29.2.8By Service Provider Model, 2020–2034
Table 29.2.9By Project Scale, 2020–2034
Table 29.2.10By Delivery Model, 2020–2034
Table 29.2.11By Regulatory and Accreditation Status, 2020–2034
Table 29.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 29.3.1.4US — Market Overview, 2020–2034, Revenue (USD Billion)
Table 29.3.1.5US — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 29.3.1.6US Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
Table 29.3.1.7US Market Overview, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 29.3.1.8US Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Table 29.3.1.9US Market Overview, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 29.3.1.10US Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Table 29.3.1.11US Market Overview, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 29.3.1.12US Market Overview, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 29.3.1.13US Market Overview, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 29.3.1.14US Market Overview, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 29.3.1.15US Market Overview, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 29.3.1.16US Market Overview, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Table 30.1Overview, 2020–2034
Table 30.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 30.2.1By Service Type, 2020–2034
Table 30.2.2By Sequencing Technology, 2020–2034
Table 30.2.3By Application, 2020–2034
Table 30.2.4By Workflow Stage, 2020–2034
Table 30.2.5By End User, 2020–2034
Table 30.2.6By Sample Type, 2020–2034
Table 30.2.7By Disease Area, 2020–2034
Table 30.2.8By Service Provider Model, 2020–2034
Table 30.2.9By Project Scale, 2020–2034
Table 30.2.10By Delivery Model, 2020–2034
Table 30.2.11By Regulatory and Accreditation Status, 2020–2034
Table 30.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 30.3.1.4Germany — Market Overview, 2020–2034, Revenue (USD Billion)
Table 30.3.1.5Germany — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 30.3.1.6Germany Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
Table 30.3.1.7Germany Market Overview, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 30.3.1.8Germany Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Table 30.3.1.9Germany Market Overview, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 30.3.1.10Germany Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Table 30.3.1.11Germany Market Overview, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 30.3.1.12Germany Market Overview, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 30.3.1.13Germany Market Overview, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 30.3.1.14Germany Market Overview, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 30.3.1.15Germany Market Overview, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 30.3.1.16Germany Market Overview, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Table 31.1Overview, 2020–2034
Table 31.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 31.2.1By Service Type, 2020–2034
Table 31.2.2By Sequencing Technology, 2020–2034
Table 31.2.3By Application, 2020–2034
Table 31.2.4By Workflow Stage, 2020–2034
Table 31.2.5By End User, 2020–2034
Table 31.2.6By Sample Type, 2020–2034
Table 31.2.7By Disease Area, 2020–2034
Table 31.2.8By Service Provider Model, 2020–2034
Table 31.2.9By Project Scale, 2020–2034
Table 31.2.10By Delivery Model, 2020–2034
Table 31.2.11By Regulatory and Accreditation Status, 2020–2034
Table 31.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 31.3.1.4India — Market Overview, 2020–2034, Revenue (USD Billion)
Table 31.3.1.5India — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 31.3.1.6India Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
Table 31.3.1.7India Market Overview, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 31.3.1.8India Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Table 31.3.1.9India Market Overview, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 31.3.1.10India Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Table 31.3.1.11India Market Overview, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 31.3.1.12India Market Overview, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 31.3.1.13India Market Overview, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 31.3.1.14India Market Overview, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 31.3.1.15India Market Overview, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 31.3.1.16India Market Overview, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Table 32.1Overview, 2020–2034
Table 32.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 32.2.1By Service Type, 2020–2034
Table 32.2.2By Sequencing Technology, 2020–2034
Table 32.2.3By Application, 2020–2034
Table 32.2.4By Workflow Stage, 2020–2034
Table 32.2.5By End User, 2020–2034
Table 32.2.6By Sample Type, 2020–2034
Table 32.2.7By Disease Area, 2020–2034
Table 32.2.8By Service Provider Model, 2020–2034
Table 32.2.9By Project Scale, 2020–2034
Table 32.2.10By Delivery Model, 2020–2034
Table 32.2.11By Regulatory and Accreditation Status, 2020–2034
Table 32.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 32.3.1.4Brazil — Market Overview, 2020–2034, Revenue (USD Billion)
Table 32.3.1.5Brazil — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 32.3.1.6Brazil Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
Table 32.3.1.7Brazil Market Overview, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 32.3.1.8Brazil Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Table 32.3.1.9Brazil Market Overview, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 32.3.1.10Brazil Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Table 32.3.1.11Brazil Market Overview, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 32.3.1.12Brazil Market Overview, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 32.3.1.13Brazil Market Overview, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 32.3.1.14Brazil Market Overview, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 32.3.1.15Brazil Market Overview, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 32.3.1.16Brazil Market Overview, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Table 33.1Overview, 2020–2034
Table 33.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 33.2.1By Service Type, 2020–2034
Table 33.2.2By Sequencing Technology, 2020–2034
Table 33.2.3By Application, 2020–2034
Table 33.2.4By Workflow Stage, 2020–2034
Table 33.2.5By End User, 2020–2034
Table 33.2.6By Sample Type, 2020–2034
Table 33.2.7By Disease Area, 2020–2034
Table 33.2.8By Service Provider Model, 2020–2034
Table 33.2.9By Project Scale, 2020–2034
Table 33.2.10By Delivery Model, 2020–2034
Table 33.2.11By Regulatory and Accreditation Status, 2020–2034
Table 33.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 33.3.1.4GCC — Market Overview, 2020–2034, Revenue (USD Billion)
Table 33.3.1.5GCC — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 33.3.1.6GCC Market Overview, By Service Type, 2020–2034, Revenue (USD Billion)
Table 33.3.1.7GCC Market Overview, By Sequencing Technology, 2020–2034, Revenue (USD Billion)
Table 33.3.1.8GCC Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Table 33.3.1.9GCC Market Overview, By Workflow Stage, 2020–2034, Revenue (USD Billion)
Table 33.3.1.10GCC Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Table 33.3.1.11GCC Market Overview, By Sample Type, 2020–2034, Revenue (USD Billion)
Table 33.3.1.12GCC Market Overview, By Disease Area, 2020–2034, Revenue (USD Billion)
Table 33.3.1.13GCC Market Overview, By Service Provider Model, 2020–2034, Revenue (USD Billion)
Table 33.3.1.14GCC Market Overview, By Project Scale, 2020–2034, Revenue (USD Billion)
Table 33.3.1.15GCC Market Overview, By Delivery Model, 2020–2034, Revenue (USD Billion)
Table 33.3.1.16GCC Market Overview, By Regulatory and Accreditation Status, 2020–2034, Revenue (USD Billion)
Scope

Questions This Report Answers

6 questions
01

What is the market size and growth rate, globally and by region?

02

How is the market segmented, and which segments lead?

03

Which regions and countries are covered, and how do they compare?

04

What are the key drivers, restraints, opportunities and challenges?

05

Who are the leading companies operating in this market?

06

What trends are expected to shape the market through the forecast period?

Questions

Frequently Asked Questions

01What is the Genomics Services Market projected to reach?

USD 36.6 USD Billion by 2034, CAGR 11.12%

02What years does this report cover?

Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.

03Which regions are covered?

North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

04Which region accounted for the largest market share?

North America leads with 41% of global revenue through 2034.

05Which segment leads the market?

Next-Generation Sequencing Services is the largest line by service type, at 46% of revenue in 2025.

06Who are the key companies profiled?

Illumina, Inc., Thermo Fisher Scientific Inc., BGI Genomics Co., Ltd., Eurofins Scientific SE, Macrogen, Inc., Psomagen, Inc., Azenta Life Sciences (GENEWIZ), Agilent Technologies, Inc., QIAGEN N.V., Novogene Co., Ltd., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies plc, Element Biosciences, Inc., 10x Genomics, Inc., Revvity, Inc., Charles River Laboratories International, Inc., Fulgent Genetics, Inc., GeneDx Holdings Corp., Invitae Corporation, Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated, Integrated DNA Technologies, Inc., CD Genomics, Genome Quebec / Genome Sciences Centre, Admera Health, LLC, Theragen Bio Co., Ltd., GenScript Biotech Corporation, Personalis, Inc.. Full profiles are part of the paid report.

07Can the segmentation be customized?

Yes. Custom data cuts by geography, segment, or competitor set are available on request.

425+
Dedicated research analysts
1,200+
Reports published
Why CDI

Why choose CDI

Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available

Need this report shaped around your question?

The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.

Most licences include 30–60 hours of customization at no extra cost. See what each licence includes

Request customization

Additional Companies

Add competitors, suppliers or the peer set you benchmark against to the companies already covered.

Deeper Competitive View

Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.

Extra Segment Splits

Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.

Application Focus

Narrow the analysis to the specific use cases and end users your team actually sells into.

Different Time Frame

Move the base year, or widen the historical and forecast windows the study is built on.

Country-Level Detail

Go below region level into the individual countries that matter to you, rather than the standard geography split.